We are live on ! Find out more
KRON

Kronos Bio
KRON

Delisted

KRON was delisted on the 20th of June, 2025.

Back to rankings

63 hedge funds and large institutions have $39.3M invested in Kronos Bio in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 13 increasing their positions, 21 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

2.92% less ownership

Funds ownership: 54.82% → 51.9% (-2.9%)

21% less funds holding

Funds holding: 80 → 63 (-17)

28% less capital invested

Capital invested by funds: $54.3M → $39.3M (-$15M)

38% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 21

85% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 20

Holders
63
Holders Change
-17
Holders Change %
-21.25%
% of All Funds
1%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
3
Increased
13
Reduced
21
Closed
20
Calls
$35K
Puts
–
Net Calls
+$35K
Net Calls Change
+$5K

Top Buyers

Rank Fund Capital Flow
1
ACP
Acuta Capital Partners
California
+$652K
2
Millennium Management
Millennium Management
New York
+$572K
3
BCM
Bridgeway Capital Management
Texas
+$292K
4
BI
BVF Inc
California
+$148K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$144K

Top Sellers

Rank Fund Capital Flow
1
Cerity Partners
Cerity Partners
New York
-$730K
2
EC
EcoR1 Capital
California
-$562K
3
GCP
GSA Capital Partners
United Kingdom
-$374K
4
Charles Schwab
Charles Schwab
California
-$367K
5
Renaissance Technologies
Renaissance Technologies
New York
-$316K
Name Holding Trade Value Shares
Change 		Change in
Stake
OFM
1
Omega Fund Management
Massachusetts
$4.96M – – –
BI
2
BVF Inc
California
$3.78M +$148K +91,558 +3%
VVA
3
Vida Ventures Advisors
Massachusetts
$3.59M – – –
PA
4
Perceptive Advisors
New York
$2.28M – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$2.19M +$144K +89,000 +6%
PCIG
6
Partners Capital Investment Group
Massachusetts
$2.17M – – –
AG
7
Artal Group
Luxembourg
$2.01M – – –
NI
8
Nextech Invest
Switzerland
$1.89M – – –
AI
9
Alphabet Inc
California
$1.87M – – –
BlackRock
10
BlackRock
New York
$1.8M -$25.8K -15,993 -1%
WCM
11
Wildcat Capital Management
New York
$1.69M – – –
Renaissance Technologies
12
Renaissance Technologies
New York
$1.3M -$316K -195,600 -16%
Millennium Management
13
Millennium Management
New York
$1.29M +$572K +354,331 +55%
Mariner
14
Mariner
Kansas
$1.19M +$3.4K +2,105 +0.2%
ACP
15
Acuta Capital Partners
California
$934K +$652K +403,739 +128%
Acadian Asset Management
16
Acadian Asset Management
Massachusetts
$798K +$59.6K +36,909 +6%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$534K +$18.8K +11,605 +3%
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$482K +$1.44K +889 +0.2%
AI
19
Acuitas Investments
Washington
$427K -$19 -12 -0%
CIA
20
Choate Investment Advisors
Massachusetts
$401K – – –
PFMU
21
Privium Fund Management (UK)
United Kingdom
$365K – – –
BCM
22
Bridgeway Capital Management
Texas
$336K +$292K +180,975 +233%
CM
23
CM Management
Florida
$325K – – –
Two Sigma Advisers
24
Two Sigma Advisers
New York
$317K -$148K -91,400 -27%
Two Sigma Investments
25
Two Sigma Investments
New York
$260K -$141K -86,992 -30%
1
2 3 4

KRON Hedge Fund Activity: Q3 2023 in Review

63 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Kronos Bio (KRON) for Q3 2023, worth a combined $39.3M — down 28% from $54.3M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of KRON and 3 opened new positions — a net loss of 17 holders — while 21 trimmed existing stakes and 13 added.

The largest buyer was Acuta Capital Partners, adding an estimated $652K. The largest seller was Cerity Partners, exiting entirely with an estimated $730K sold.

  • 63 institutional investors held Kronos Bio (KRON) as of Q3 2023, down from 80 in Q2 2023.
  • Funds reported $39.3M of Kronos Bio stock for Q3 2023, down 28% quarter-over-quarter.
  • 3 funds opened new Kronos Bio positions in Q3 2023 and 20 closed out, a net change of -17 holders.
  • The largest Kronos Bio buyer in Q3 2023 was Acuta Capital Partners, an estimated $652K added.
  • The largest Kronos Bio seller in Q3 2023 was Cerity Partners, an estimated $730K sold.

Based on aggregated 13F filings for Q3 2023.